User profiles for N. Dupre

Nicolas Dupre

Université Laval
Verified email at fmed.ulaval.ca
Cited by 9134

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

…, PF Pradat, W Camu, V Meininger, N Dupre… - Nature …, 2008 - nature.com
Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in
amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the …

[HTML][HTML] The classification of autosomal recessive cerebellar ataxias: a consensus statement from the society for research on the cerebellum and ataxias task force

…, M Manto, GA Rouleau, C Klein, N Dupre - The Cerebellum, 2019 - Springer
There is currently no accepted classification of autosomal recessive cerebellar ataxias, a
group of disorders characterized by important genetic heterogeneity and complex phenotypes. …

NMR studies of cathode materials for lithium-ion rechargeable batteries

CP Grey, N Dupré - Chemical reviews, 2004 - ACS Publications
… energies at or very close to E f (ie, N(E f ) Li,2s the Li 2s partial density of states at the Fermi
level; this can be quite different than the value of N(E f ) that is important in controlling the …

Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian expert panel

…, S Sirrs, HB Sarnat, K Myers, N Dupré… - Canadian Journal of …, 2016 - cambridge.org
Pompe disease is a lysosomal storage disorder caused by a deficiency of the enzyme acid
alpha-glucosidase. Patients have skeletal muscle and respiratory weakness with or without …

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

T Voss, RB Lipton, DW Dodick, N Dupre, JY Ge… - …, 2016 - journals.sagepub.com
Aim The aim of this trial was to evaluate the efficacy and tolerability of ubrogepant (MK-1602),
a calcitonin gene-related peptide receptor antagonist (CGRP-RA), for the acute treatment …

Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis

…, PN Valdmanis, E Kabashi, P Dion, N Dupre… - Journal of medical …, 2009 - jmg.bmj.com
Aims and background: Mutations in the TARDBP gene, which encodes the TAR DNA
binding protein (TDP-43), have been described in individuals with familial and sporadic …

[PDF][PDF] Exome sequencing identifies FUS mutations as a cause of essential tremor

…, M Belouchi, M Panisset, P Cossette, N Dupré… - The American Journal of …, 2012 - cell.com
… A recent meta-analysis that used population-based studies (n ¼ 28) estimated that the pooled
prevalence of ET (at all ages) was 0.9%2 and found that there is an increasing prevalence …

Vitamin d–related genetic variation, plasma vitamin d, and risk of lethal prostate cancer: A prospective nested case–control study

…, K Nimptsch, BW Hollis, N DuPre… - Journal of the …, 2012 - academic.oup.com
… For each confirmed case patient who received a diagnosis of prostate cancer after having
sent a blood sample, we randomly selected a control subject (n = 1331) from among those …

[HTML][HTML] Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

…, FC Mercado, G Sorrentino, N Dupre… - European Journal of …, 2002 - nature.com
Chorea-acanthocytosis (ChAc) is an autosomal recessive neurological disorder whose
characteristic features include hyperkinetic movements and abnormal red blood cell morphology. …

Mutations in FUS cause FALS and SALS in French and French Canadian populations

…, PF Pradat, W Camu, V Meininger, N Dupre… - Neurology, 2009 - AAN Enterprises
Background: The identification of mutations in the TARDBP and more recently the identification
of mutations in the FUS gene as the cause of amyotrophic lateral sclerosis (ALS) is …